Artem is the founder and chief executive of Mission Street which he founded in 2017.
Over a short period, he has built the company into one of the UK’s leading specialist investors and developers in science and innovation real estate, with a committed development pipeline in excess of 1.5million sq ft.
Building on an extensive track record across investment, development and finance, Artem has overall strategic responsibility for the growth of the company, project delivery and management.
Prior to Mission Street, Artem was Head of UK Acquisitions and a member of the founding team of GreenOak Real Estate (now BGO), a major international real estate investment and asset management firm.
He previously worked for Morgan Stanley in their UK Real Estate team.
Artem’s track record spans development, asset management, real estate private equity and finance.
He graduated with an MA (First Class Honours) in Land Economy from the University of Cambridge and sits on the Investment and Development Committee of the Institute of Cancer Research.
Artem is the founder and chief executive of Mission Street which he founded in 2017.
Over a short period, he has built the company into one of the UK’s leading specialist investors and developers in science and innovation real estate, with a committed development pipeline in excess of 1.5million sq ft.
Building on an extensive track record across investment, development and finance, Artem has overall strategic responsibility for the growth of the company, project delivery and management.
Prior to Mission Street, Artem was Head of UK Acquisitions and a member of the founding team of GreenOak Real Estate (now BGO), a major international real estate investment and asset management firm.
He previously worked for Morgan Stanley in their UK Real Estate team.
Artem’s track record spans development, asset management, real estate private equity and finance.
He graduated with an MA (First Class Honours) in Land Economy from the University of Cambridge and sits on the Investment and Development Committee of the Institute of Cancer Research.